B of A Securities Maintains Neutral on Hims & Hers Health, Lowers Price Target to $25

Benzinga Newsdesk www.benzinga.com Neutral 59.3%

Neg 0% Neu 59.3% Pos 0%

B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and lowers the price target from $28 to $25.